- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
4
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 companies
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩31,050.00
7D
3.0%
1Y
-8.9%
ALTEOGEN
Market Cap: ₩16.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩300,500.00
7D
8.7%
1Y
-35.0%
HansBiomed
Market Cap: ₩280.9b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩19,700.00
7D
-3.2%
1Y
138.8%
DreamCIS
Market Cap: ₩70.6b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩2,870.00
7D
-0.2%
1Y
-12.0%